![]() Be alert to hypokalemia or hyperglycemia.Use caution in patients with convulsive disorders, thyrotoxicosis, diabetes mellitus, and ketoacidosis or unusually responsive to sympathomimetic amines.Instruct patients to contact a healthcare provider immediately if symptoms occur Use with caution in patients with prostatic hyperplasia or bladder-neck obstruction. Worsening of urinary retention may occur.Consider referral to an ophthalmologist in patients who develop ocular symptoms or use BREZTRI long term. Worsening of narrow-angle glaucoma may occur, so use with caution. Glaucoma and cataracts may occur with long-term use of ICS.Assess initially and periodically thereafter in patients at high risk for decreased bone mineral content ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |